VaxEquity
Cambridge
About VaxEquity
VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines. It utilizes saRNA to provide greatly enhanced protein expression, combining better tolerability with slower release and thermostability.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $870.3K
- Funding stage: Seed
- Last round: Grant (Jun 2023)
- Website: vaxequity.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vaxequity-112386 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.